{"id":174929,"date":"2025-12-09T00:34:07","date_gmt":"2025-12-09T00:34:07","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/174929\/"},"modified":"2025-12-09T00:34:07","modified_gmt":"2025-12-09T00:34:07","slug":"lawmaker-asks-what-happened-to-federal-investigation-into-predatory-for-profit-dialysis-industry","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/174929\/","title":{"rendered":"Lawmaker asks what happened to federal investigation into &#8220;predatory&#8221; for-profit dialysis industry"},"content":{"rendered":"<p>A leading U.S. senator is calling on federal regulators to share the results of an investigation into the dialysis industry, where critics say a &#8220;duopoly&#8221; has compromised the quality of critical, lifesaving kidney care.<\/p>\n<p>Two companies now own nearly 75% of all U.S. dialysis clinics \u2014 nearly 5,600 in total, a CBS News investigation reported earlier this year. Sen. Richard Blumenthal, a Connecticut Democrat, said in an interview with CBS News he is troubled by the &#8220;hallmarks of unlawful abuse of market power.&#8221;\u00a0<\/p>\n<p>&#8220;The government may feel it has no leverage against two companies that provide for almost all the dialysis treatment in the country,&#8221; Blumenthal said in an interview with CBS News. &#8220;But it has failed to use more leverage, including its antitrust powers against those companies.&#8221;<\/p>\n<p>The FTC, which polices the business world for anti-competitive conduct, had been probing whether the two companies&#8217; lock on the market impacted patient care, Blumenthal said, but any findings have not been made public. Blumenthal said he has requested the agency &#8220;take appropriate robust enforcement action to remediate issues it has identified and protect patients, including veterans, from misconduct by these companies.&#8221;<\/p>\n<p>Roughly 500,000 Americans depend on dialysis to stay alive as they <a href=\"https:\/\/www.cbsnews.com\/news\/kidney-transplant-dialysis-perfect-match\/\" target=\"_blank\" data-invalid-url-rewritten-http=\"\" rel=\"nofollow noopener\">wait and hope<\/a> for a <a href=\"https:\/\/www.kidneyregistry.com\/\" target=\"_blank\" rel=\"nofollow noopener\">kidney transplant<\/a>. The centers, where patients come to have their blood filtered offer\u00a0 the only available remedy for most suffering from end-stage <a href=\"https:\/\/www.kidney.org\/\" target=\"_blank\" rel=\"nofollow noopener\">kidney disease<\/a>. Critics of the industry allege the leading companies that provide that care, Fresenius and DaVita, have become too focused on profits.<\/p>\n<p>&#8220;This is emergency room care done in the mall,&#8221; said Tom Mueller, the author of &#8220;How to Make a Killing: Blood, Death and Dollars in American Medicine,&#8221; who spent more than five years studying the dialysis industry. &#8220;People are not given the tailored treatment that they need.&#8221;<\/p>\n<p>The companies have for three decades been creeping towards &#8220;a duopoly,&#8221; according to Ryan McDevitt, a Duke University economist who spoke to CBS News earlier this year about the issue.<\/p>\n<p>&#8220;This is the most concentrated health care sector across the entire U.S.,&#8221; McDevitt said.<\/p>\n<p>The <a href=\"https:\/\/www.cbsnews.com\/dialysis\/\" target=\"_blank\" rel=\"nofollow noopener\" data-invalid-url-rewritten-http=\"\">CBS News review of federal data<\/a> found one-third of dialysis clinics failed to meet federal standards this year \u2014 nearly 2,500 of the roughly 7,600 clinics nationwide. The average score was 60 out of 100 possible points.<\/p>\n<p>In separate statements to CBS News, both companies highlighted their performance, saying the data reflects a track record of &#8220;exemplary care.&#8221;<\/p>\n<p>McDevitt argued that Medicare&#8217;s limits on how much it reimburses clinics per patient have incentivized DaVita and Fresenius to focus on filling chairs to increase their profit margins. Both companies reject that characterization.<\/p>\n<p>Last year alone, DaVita delivered more than <a href=\"https:\/\/investors.davita.com\/2025-02-13-DaVita-Inc-4th-Quarter-2024-Results\" target=\"_blank\" rel=\"nofollow noopener\">29 million dialysis treatments<\/a>, earning $391 in revenue per session, and Davita and Fresenius reported a total of $33.7 billion in revenue.<\/p>\n<p>McDevitt said his research found that over the last twenty years, when independent clinics are acquired by DaVita or Fresenius, their transplant referrals drop by about 10%, their patient survival rates fall by 2%, hospitalizations increase by 5%, and infection rates go up by about 12%.<\/p>\n<p>Criticism of the industry has been disputed by the two for-profit companies. Fresenius told CBS News in a statement this summer that the company maintains an &#8220;unwavering focus on improving quality of life, strengthening clinical outcomes, and extending the lifespan of those we have the privilege to serve.&#8221; DaVita said in a statement that its &#8220;dedicated clinicians consistently deliver high-quality, individualized care in a complex clinical and regulatory environment.&#8221;<\/p>\n<p>For years, health surveyors from the Center for Medicare and Medicaid Services (CMS) have conducted routine monitoring of dialysis clinics to assess their performance.<\/p>\n<p>Since 2013, those officials have cited U.S. dialysis centers for more than 115,000 deficiencies, including poor hand hygiene, unsanitary conditions while handling IV medications, and inadequate training.<\/p>\n<p>Fresenius noted that more than 65% of its dialysis centers received three stars or higher on Medicare&#8217;s five-star scale \u2014 a rate the company said is higher than the national average of all U.S. dialysis providers. The company also said its employees &#8220;take immense pride in providing best-in-class, high-quality care to our patients.&#8221;<\/p>\n<p>DaVita said in a statement to CBS News that problems in clinics were &#8220;rare and isolated&#8221; and represent &#8220;exceptions and do not reflect the exemplary care we consistently provide.&#8221;<\/p>\n<p>&#8220;We take every concern seriously, and if we make an error, we work immediately to resolve it,&#8221; DaVita said in its statement. &#8220;To mischaracterize such anomalies as systemic care failures is reckless, fear-mongering, and puts patient well-being at risk.&#8221;<\/p>\n<p>Blumenthal noted that one group that has seen greater reliance on the for-profit clinics are those who served in the American military. Some 40,000 veterans depend on dialysis to stay alive as they wait and hope for a kidney transplant, the only available remedy for those suffering from end-stage kidney disease.<\/p>\n<p>In his letter to FTC Chairman Andrew Ferguson, Blumenthal called on the agency to &#8220;take appropriate robust enforcement action to remediate issues it has identified and protect patients, including veterans, from misconduct by these companies.&#8221;<\/p>\n<p>&#8220;This industry is ripe with predatory, monopolistic potential practices,&#8221; Blumenthal alleged in the letter, adding that the &#8220;anti-competitive anti consumer situation, and it cries out for the kind of investigation that the FTC would do.&#8221;\u00a0<\/p>\n<p>In a statement to CBS News, Fresenius said, &#8220;We are aware of the inquiry and are fully cooperating with the FTC. As this is an ongoing investigation, we cannot comment any further.&#8221;<\/p>\n<p>The FTC and DaVita did not immediately respond to requests for comment.<\/p>\n<p>\n        More from CBS News\n      <\/p>\n","protected":false},"excerpt":{"rendered":"A leading U.S. senator is calling on federal regulators to share the results of an investigation into the&hellip;\n","protected":false},"author":2,"featured_media":174930,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[66388,10885,163,521,85,46,5581],"class_list":{"0":"post-174929","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-dialysis","9":"tag-federal-trade-commission","10":"tag-health","11":"tag-healthcare","12":"tag-il","13":"tag-israel","14":"tag-richard-blumenthal"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/174929","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=174929"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/174929\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/174930"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=174929"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=174929"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=174929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}